Drug search by name

Olaratumab Intravenous and Hepatic impairment

Result of checking the interaction of drug Olaratumab Intravenous and disease Hepatic impairment for safety when used together.

Check result:

Olaratumab Intravenous <> Hepatic impairment

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Olaratumab population pharmacokinetic analysis in patients with mild to moderate hepatic impairment indicated that hepatic impairment had no clinically important effect on the pharmacokinetics of olaratumab. The pharmacokinetics of olaratumab in patients with severe hepatic impairment is unknown. Care and close monitoring should be exercised when using this agent in patients with severe hepatic impairment.

Olaratumab Intravenous

Generic Name: olaratumab

Brand Name: Lartruvo

Synonyms: Olaratumab

What is Olaratumab Intravenous?